Overview
Luis Tinao-Aponte practices in Argentina. Mr. Tinao-Aponte is highly rated in 6 conditions, according to our data. His top areas of expertise are Bone Tumor, Chondrosarcoma, Adult Soft Tissue Sarcoma, Bone Graft, and Osteotomy.
His clinical research consists of co-authoring 64 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bone GraftMr. Tinao-Aponte isDistinguished. Learn about Bone Graft.
- Bone TumorMr. Tinao-Aponte isDistinguished. Learn about Bone Tumor.
- OsteotomyMr. Tinao-Aponte isDistinguished. Learn about Osteotomy.
- Advanced
- Adult Soft Tissue SarcomaMr. Tinao-Aponte isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- ChondrosarcomaMr. Tinao-Aponte isAdvanced. Learn about Chondrosarcoma.
- OsteosarcomaMr. Tinao-Aponte isAdvanced. Learn about Osteosarcoma.
- Experienced
- Accessory Navicular BoneMr. Tinao-Aponte isExperienced. Learn about Accessory Navicular Bone.
- ChondroblastomaMr. Tinao-Aponte isExperienced. Learn about Chondroblastoma.
- Ewing SarcomaMr. Tinao-Aponte isExperienced. Learn about Ewing Sarcoma.
- Fibrous DysplasiaMr. Tinao-Aponte isExperienced. Learn about Fibrous Dysplasia.
- Lung MetastasesMr. Tinao-Aponte isExperienced. Learn about Lung Metastases.
- NecrosisMr. Tinao-Aponte isExperienced. Learn about Necrosis.